HepatitisC
| 3:45PM 11/02/2009
News that Amylin Pharmaceuticals (AMLN) inked a billion-dollar development deal with Takeda Pharmaceutical for new obesity therapies was among the favorable developments in the sector on Monday that pushed several key stocks higher. Amylin shares were up nearly 10 percent in late trading after...